Targeted sequencing of cohesin genes in 389 AML samples. Cohesin mutations significantly co-occurred with NPM1 mutations. Allelic burden analysis suggested cohesin mutations occurred early in AML. This evidence concerns the gene NPM1 and acute myeloid leukemia.